{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:54:44Z","timestamp":1787068484759,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,6,14]],"date-time":"2012-06-14T00:00:00Z","timestamp":1339632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s10495-012-0739-9","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T07:47:02Z","timestamp":1339573622000},"page":"950-963","source":"Crossref","is-referenced-by-count":11,"title":["Increased acetylation of lysine 317\/320 of p53 caused by BCR-ABL protects from cytoplasmic translocation of p53 and mitochondria-dependent apoptosis in response to DNA damage"],"prefix":"10.1007","volume":"17","author":[{"given":"Monika","family":"Kusio-Kobialka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Wolanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Podszywalow-Bartnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Skowronek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Ghizzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Piwocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,14]]},"reference":[{"key":"739_CR1","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.1140735","volume":"319","author":"TD Halazonetis","year":"2008","unstructured":"Halazonetis TD, Gorgoulis VG, Bartek J (2008) An oncogene-induced DNA damage model for cancer development. Science 319:1352\u20131355","journal-title":"Science"},{"key":"739_CR2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.mad.2007.05.002","volume":"128","author":"JH Hoeijmakers","year":"2007","unstructured":"Hoeijmakers JH (2007) Genome maintenance mechanisms are critical for preventing cancer as well as other aging-associated diseases. Mech Ageing Dev 128:460\u2013462","journal-title":"Mech Ageing Dev"},{"key":"739_CR3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/1-4020-3764-3_6","volume":"570","author":"PA Jeggo","year":"2005","unstructured":"Jeggo PA (2005) Genomic instability in cancer development. Adv Exp Med Biol 570:175\u2013197","journal-title":"Adv Exp Med Biol"},{"key":"739_CR4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc2716","volume":"9","author":"DW Meek","year":"2009","unstructured":"Meek DW (2009) Tumour suppression by p53: a role for the DNA damage response? Nat Rev Cancer 9:714\u2013723","journal-title":"Nat Rev Cancer"},{"key":"739_CR5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","volume":"7","author":"JV Melo","year":"2007","unstructured":"Melo JV, Barnes DJ (2007) Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 7:441\u2013453","journal-title":"Nat Rev Cancer"},{"key":"739_CR6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1634\/theoncologist.5-5-405","volume":"5","author":"A Bacco Di","year":"2000","unstructured":"Di Bacco A, Keeshan K, McKenna SL, Cotter TG (2000) Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis. Oncologist 5:405\u2013415","journal-title":"Oncologist"},{"key":"739_CR7","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1038\/sj.onc.1207116","volume":"22","author":"JS Fridman","year":"2003","unstructured":"Fridman JS, Lowe SW (2003) Control of apoptosis by p53. Oncogene 22:9030\u20139040","journal-title":"Oncogene"},{"key":"739_CR8","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.4161\/cc.7.13.6222","volume":"7","author":"L Galluzzi","year":"2008","unstructured":"Galluzzi L, Morselli E, Kepp O, Tajeddine N, Kroemer G (2008) Targeting p53 to mitochondria for cancer therapy. Cell Cycle 7:1949\u20131955","journal-title":"Cell Cycle"},{"key":"739_CR9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1515\/BC.2008.039","volume":"389","author":"M Pietrzak","year":"2008","unstructured":"Pietrzak M, Puzianowska-Kuznicka M (2008) p53-Dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter. Biol Chem 389:383\u2013393","journal-title":"Biol Chem"},{"key":"739_CR10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tcb.2009.10.002","volume":"20","author":"D Speidel","year":"2010","unstructured":"Speidel D (2010) Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol 20:14\u201324","journal-title":"Trends Cell Biol"},{"key":"739_CR11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1535-6108(03)00272-1","volume":"4","author":"JE Chipuk","year":"2003","unstructured":"Chipuk JE, Maurer U, Green DR, Schuler M (2003) Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell 4:371\u2013381","journal-title":"Cancer Cell"},{"key":"739_CR12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nrc2012","volume":"6","author":"F Toledo","year":"2006","unstructured":"Toledo F, Wahl GM (2006) Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 6:909\u2013923","journal-title":"Nat Rev Cancer"},{"key":"739_CR13","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.2741\/3524","volume":"14","author":"I Ferecatu","year":"2009","unstructured":"Ferecatu I, Rincheval V, Mignotte B, Vayssiere JL (2009) Tickets for p53 journey among organelles. Front Biosci 14:4214\u20134228","journal-title":"Front Biosci"},{"key":"739_CR14","doi-asserted-by":"crossref","first-page":"11171","DOI":"10.1074\/jbc.M809268200","volume":"284","author":"H Yamaguchi","year":"2009","unstructured":"Yamaguchi H, Woods NT, Piluso LG, Lee HH, Chen J, Bhalla KN, Monteiro A, Liu X, Hung MC, Wang HG (2009) p53 Acetylation is crucial for its transcription-independent proapoptotic functions. J Biol Chem 284:11171\u201311183","journal-title":"J Biol Chem"},{"issue":"5","key":"739_CR15","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0092-8674(00)82001-2","volume":"87","author":"VV Ogryzko","year":"1996","unstructured":"Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y (1996) The transcription coactivators p300 and CBP are histone acetyltransferases. Cell 87(5):953\u2013959","journal-title":"Cell"},{"issue":"2","key":"739_CR16","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1128\/MCB.19.2.1202","volume":"19","author":"L Liu","year":"1999","unstructured":"Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD, Berger SL (1999) p53 Sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 19(2):1202\u20131209","journal-title":"Mol Cell Biol"},{"key":"739_CR17","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1101\/gad.12.18.2831","volume":"12","author":"K Sakaguchi","year":"1998","unstructured":"Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson CW, Appella E (1998) DNA damage activates p53 through a phosphorylation\u2013acetylation cascade. Genes Dev 12:2831\u20132841","journal-title":"Genes Dev"},{"key":"739_CR18","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1124\/jpet.107.124461","volume":"322","author":"SM Lee","year":"2007","unstructured":"Lee SM, Bae JH, Kim MJ, Lee HS, Lee MK, Chung BS, Kim DW, Kang CD, Kim SH (2007) Bcr-Abl-independent imatinib-resistant K562 cells show aberrant protein acetylation and increased sensitivity to histone deacetylase inhibitors. J Pharmacol Exp Ther 322:1084\u20131092","journal-title":"J Pharmacol Exp Ther"},{"key":"739_CR19","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1080\/03093640701859089","volume":"49","author":"T Skorski","year":"2008","unstructured":"Skorski T (2008) BCR\/ABL, DNA damage and DNA repair: implications for new treatment concepts. Leuk Lymphoma 49:610\u2013614","journal-title":"Leuk Lymphoma"},{"key":"739_CR20","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1158\/0008-5472.CAN-07-6858","volume":"68","author":"T Stoklosa","year":"2008","unstructured":"Stoklosa T, Poplawski T, Koptyra M, Nieborowska-Skorska M, Basak G, Slupianek A, Rayevskaya M, Seferynska I, Herrera L, Blasiak J, Skorska T (2008) BCR\/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations. Cancer Res 68:2576\u20132580","journal-title":"Cancer Res"},{"key":"739_CR21","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/sj.leu.2402309","volume":"15","author":"K Keeshan","year":"2001","unstructured":"Keeshan K, Mills KI, Cotter TG, McKenna SL (2001) Elevated Bcr-Abl expression levels are sufficient for a haematopoietic cell line to acquire a drug-resistant phenotype. Leukemia 15:1823\u20131833","journal-title":"Leukemia"},{"key":"739_CR22","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/sj.leu.2402576","volume":"16","author":"K Keeshan","year":"2002","unstructured":"Keeshan K, Cotter TG, McKenna SL (2002) High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion. Leukemia 16:1725\u20131734","journal-title":"Leukemia"},{"issue":"16","key":"739_CR23","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1016\/j.bmc.2010.06.089","volume":"18","author":"M Ghizzoni","year":"2010","unstructured":"Ghizzoni M, Boltjes A, Graaf C, Haisma HJ, Dekker FJ (2010) Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative. Bioorg Med Chem 18(16):5826\u20135834","journal-title":"Bioorg Med Chem"},{"key":"739_CR24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ceb.2005.09.007","volume":"17","author":"UM Moll","year":"2005","unstructured":"Moll UM, Wolff S, Speidel D, Deppert W (2005) Transcription-independent pro-apoptotic functions of p53. Curr Opin Cell Biol 17:631\u2013636","journal-title":"Curr Opin Cell Biol"},{"issue":"5660","key":"739_CR25","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1092734","volume":"303","author":"JE Chipiuk","year":"2004","unstructured":"Chipiuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303(5660):1010\u20131014","journal-title":"Science"},{"issue":"9","key":"739_CR26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nchembio809","volume":"2","author":"E Strom","year":"2006","unstructured":"Strom E, Sahte S, Komaroy PG, Chernova OB, Pavlovska I, Shynhynova I, Bosykh DA, Burdelya LG, Macklis RM, Skaliter R, Komarova EA, Gudkov AV (2006) Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat Chem Biol 2(9):474\u2013479","journal-title":"Nat Chem Biol"},{"issue":"5","key":"739_CR27","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1074\/jbc.M109.065391","volume":"285","author":"F Hagn","year":"2010","unstructured":"Hagn F, Klein C, Demmer O, Marchenko N, Vaseya A, Moll UM, Kessler H (2010) BclxL changes conformation upon binding to wild-type but not mutant p53 DNA binding domain. J Biol Chem 285(5):3439\u20133450","journal-title":"J Biol Chem"},{"key":"739_CR28","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1046\/j.1432-1327.2001.02227.x","volume":"268","author":"SH Liang","year":"2001","unstructured":"Liang SH, Clarke MF (2001) Regulation of p53 localization. Eur J Biochem 268:2779\u20132783","journal-title":"Eur J Biochem"},{"issue":"2","key":"739_CR29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.bmc.2008.12.008","volume":"17","author":"FJ Dekker","year":"2009","unstructured":"Dekker FJ, Ghizzoni M, van der Meer N, Wisastra R, Haisma HJ (2009) Inhibition of the PCAF histone acetyl transferase and cell proliferation by isothiazolones. Bioorg Med Chem 17(2):460\u2013466","journal-title":"Bioorg Med Chem"},{"issue":"7242","key":"739_CR30","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/nature07986","volume":"458","author":"DR Green","year":"2009","unstructured":"Green DR, Kroemer G (2009) Cytoplasmic functions of the tumour suppressor p53. Nature 458(7242):1127\u20131130","journal-title":"Nature"},{"key":"739_CR31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.tig.2005.01.001","volume":"21","author":"M Schuler","year":"2005","unstructured":"Schuler M, Green DR (2005) Transcription, apoptosis and p53: catch-22. Trends Genet 21:182\u2013187","journal-title":"Trends Genet"},{"key":"739_CR32","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.onc.1209126","volume":"25","author":"D Speidel","year":"2006","unstructured":"Speidel D, Helmbold H, Deppert W (2006) Dissection of transcriptional and non-transcriptional p53 activities in the response to genotoxic stress. Oncogene 25:940\u2013953","journal-title":"Oncogene"},{"key":"739_CR33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4161\/cc.3.4.821","volume":"3","author":"JE Chipuk","year":"2004","unstructured":"Chipuk JE, Green DR (2004) Cytoplasmic p53: Bax and forward. Cell Cycle 3:429\u2013431","journal-title":"Cell Cycle"},{"issue":"3","key":"739_CR34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.molcel.2010.10.019","volume":"40","author":"E Gavathiotis","year":"2010","unstructured":"Gavathiotis E, Reyna DE, Davis ML, Bird GH, Walensky LD (2010) BH3-triggered structural reorganization drives the activation of proapoptotic BAX. Moll Cell 40(3):481\u2013492","journal-title":"Moll Cell"},{"issue":"2","key":"739_CR35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/35101031","volume":"1","author":"AG Knudson","year":"2001","unstructured":"Knudson AG (2001) Two genetic hits (more or less) to cancer. Nat Rev Cancer 1(2):157\u2013162","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"739_CR36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jmb.2008.09.041","volume":"384","author":"BA Callus","year":"2008","unstructured":"Callus BA, Moujallad DM, Silke J, Gerl R, Jabbour AM, Ekert PG, Vaux DL (2008) Triggering apoptosis by Puma is determined by the he threshold set by prosurvival Bcl-2 family proteins. J Mol Biol 384(2):313\u2013323","journal-title":"J Mol Biol"},{"issue":"3","key":"739_CR37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1535-6108(02)00126-5","volume":"2","author":"K Degenhart","year":"2002","unstructured":"Degenhart K, Chen G, Lindsten T, White E (2002) BAX and BAK mediate p53-independent suppression of tumorigenesis. Cancer Cell 2(3):193\u2013203","journal-title":"Cancer Cell"},{"key":"739_CR38","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1128\/MCB.00062-06","volume":"26","author":"C Chao","year":"2006","unstructured":"Chao C, Wu Z, Mazur SJ, Borges H, Rossi M, Lin T, Wang J, Anderson CW, Appella E, Xu Y (2006) Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage. Mol Cell Biol 26:6859\u20136869","journal-title":"Mol Cell Biol"},{"key":"739_CR39","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1083\/jcb.200512059","volume":"173","author":"CD Knights","year":"2006","unstructured":"Knights CD, Catania J, Di Giovanni S, Muratoglu S, Perez R, Swartzbeck A, Quong AA, Zhang X, Beerman T, Pestell RG, Avantaggiati ML (2006) Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J Cell Biol 173:533\u2013544","journal-title":"J Cell Biol"},{"issue":"3","key":"739_CR40","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S1097-2765(03)00050-9","volume":"11","author":"M Mihara","year":"2003","unstructured":"Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, Moll UM (2003) p53 Has a direct apoptogenic role at the mitochondria. Mol Cell 11(3):577\u2013590","journal-title":"Mol Cell"},{"issue":"6","key":"739_CR41","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.191.6.977","volume":"191","author":"M Horita","year":"2000","unstructured":"Horita M, Andreu EJ, Benito A, Arbona C, Sanz C, Benet I, Prosper F, Fernandez-Luna JL (2000) Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL. J Exp Med 191(6):977\u2013984","journal-title":"J Exp Med"},{"issue":"4","key":"739_CR42","first-page":"141","volume":"2","author":"L Bai","year":"2006","unstructured":"Bai L, Zhu W-G (2006) p53: structure, function and therapeutic applications. J Cancer Mol 2(4):141\u2013153","journal-title":"J Cancer Mol"},{"issue":"52","key":"739_CR43","doi-asserted-by":"crossref","first-page":"50607","DOI":"10.1074\/jbc.C200578200","volume":"277","author":"M Li","year":"2002","unstructured":"Li M, Luo J, Brooks CL, Gu W (2002) Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 277(52):50607\u201350611","journal-title":"J Biol Chem"},{"issue":"4","key":"739_CR44","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2006.09.031","volume":"127","author":"L Cam Le","year":"2006","unstructured":"Le Cam L, Linares LK, Paul C, Julien E, Lacroix M, Hatchi E, Triboulet R, Bossis G, Shmueli A, Rodriguez MS, Coux O, Sardet C (2006) E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation. Cell 127(4):775\u2013788","journal-title":"Cell"},{"issue":"4","key":"739_CR45","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/sj.emboj.7601560","volume":"26","author":"ND Marchenko","year":"2007","unstructured":"Marchenko ND, Wolff S, Erster S, Becker K, Moll UM (2007) Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J 26(4):923\u2013934","journal-title":"EMBO J"},{"issue":"45","key":"739_CR46","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1038\/sj.onc.1209641","volume":"25","author":"G Palacios","year":"2006","unstructured":"Palacios G, Moll UM (2006) Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo. Oncogene 25(45):6133\u20136139","journal-title":"Oncogene"},{"issue":"5741","key":"739_CR47","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1126\/science.1114297","volume":"309","author":"JE Chipuk","year":"2005","unstructured":"Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR (2005) PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309(5741):1732\u20131735","journal-title":"Science"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-012-0739-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-012-0739-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-012-0739-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T19:26:24Z","timestamp":1561836384000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-012-0739-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,14]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["739"],"URL":"https:\/\/doi.org\/10.1007\/s10495-012-0739-9","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,14]]}}}